German research network "Applied Surveillance and Testing" - Workpackage schools and Nurseries (COVID-19)

Organizational Data

DRKS-ID:
DRKS00023911
Recruitment Status:
Recruiting complete, study complete
Date of registration in DRKS:
2020-12-18
Last update in DRKS:
2021-04-30
Registration type:
Retrospective

Acronym/abbreviation of the study

B-FAST Schools and Nurseries

URL of the study

https://kinderklinik.uk-koeln.de/forschung/b-fast/

Brief summary in lay language

The long-term goal of this study is to prevent school closures in the SARS-CoV-2 pandemic. To achieve this, study participants at school facilities will be tested closely for SARS-CoV-2 using various methods. The primary objective is to investigate the acceptability of this close-meshed testing.

Brief summary in scientific language

B-FAST is a project of the National Research Network of University Hospitals in Germany, funded by the German Federal Ministry of Education and Research. The aim of the overall project is to contribute to the management of the SARS-CoV-2 and COVID-19 pandemic. SARS-CoV-2 and the resulting COVID-19 pandemic pose comprehensive challenges to our society. The role of children and adolescents in the spread of the virus has not yet been conclusively determined; they appear to play a role in the SARS-CoV-2 pandemic as possible carriers and often show mild courses of the disease or may present asymptomatically. Clearance and hygiene rules are difficult to enforce among minors and are inconsistently applied in different states. Moreover, in schools and childcare facilities, many people congregate in a confined space during regular operations. The operation of schools is a risk factor for cluster outbreaks of SARS-CoV-2, and the phenomenon of so-called superspreaders exacerbates this situation. The widespread reopening of schools and daycare centers must not jeopardize further containment of the pandemic. This creates a dilemma with the goal of pandemic control and protection of the vulnerable elderly population on the one hand, and the equally important right to education and care for children on the other. Serious social consequences are to be feared, potentially jeopardizing the acceptance of measures in the context of pandemic plans. The overall effectiveness of school closures is also controversial, depending largely on the timing of their implementation. Nevertheless, models show that school closures alone are not effective interventions and that individual school interventions tend to be both more effective and more cost-efficient. However, no valid data exist on the safety of resuming school operations, and no clear recommendations for action could be derived from previous epidemics in this regard. School closings result in high direct and indirect costs. In addition, together with other quarantine measures, they pose a significant risk for the development of psychiatric disorders. Models suggest that long-term surveillance is urgently required to enable maintenance of social life in the post-pandemic phase of COVID-19. The concept to be investigated in this project is therefore to prevent school closures in the context of cluster outbreaks by providing close virological surveillance of all individuals at community sites over a defined period of time (surveillance). The main focus of this study lies on the feasibility and the acceptance of the provided multiple screenings, in order to not only theoretically plan an already recorded problem area (pandemic plan), but to enable a rapid and broad implementation ('rapid response'). The study will be conducted multicentrally at five sites in Germany (Düsseldorf, Heidelberg, Homburg, Cologne, Munich) . At all sites, the responsible health authority is involved in the planning.

Health condition or problem studied

Free text:
SARS-CoV-2
Healthy volunteers:
No Entry

Interventions, Observational Groups

Arm 1:
Oropharyngeal swab for SARS-CoV-2 on 2 or 3 test days per week, for a period of 3 weeks.
Arm 2:
Saliva sample to be tested for SARS-CoV-2, on 2 or 3 days per week, for a period of 3 weeks.

Endpoints

Primary outcome:
acceptance and feasibility of testing for SARS-CoV-2 in schools and nurseries
Secondary outcome:
Review of child-friendly and everyday sampling methods for the detection and surveillance of SARS-CoV-2 and other respiratory viruses

Study Design

Purpose:
Screening
Allocation:
Randomized controlled study
Control:
  • Other
Phase:
N/A
Study type:
Interventional
Mechanism of allocation concealment:
No Entry
Blinding:
No
Assignment:
Factorial
Sequence generation:
No Entry
Who is blinded:
No Entry

Recruitment

Recruitment Status:
Recruiting complete, study complete
Reason if recruiting stopped or withdrawn:
No Entry

Recruitment Locations

Recruitment countries:
  • Germany
Number of study centers:
Multicenter study
Recruitment location(s):
  • University medical center Köln
  • University medical center Heidelberg
  • University medical center Homburg
  • University medical center München
  • University medical center Düsseldorf

Recruitment period and number of participants

Planned study start date:
No Entry
Actual study start date:
2020-10-18
Planned study completion date:
No Entry
Actual Study Completion Date:
2021-03-26
Target Sample Size:
7500
Final Sample Size:
4081

Inclusion Criteria

Sex:
All
Minimum Age:
1 Years
Maximum Age:
no maximum age
Additional Inclusion Criteria:
Pupils of the participating institution and employees of the participating institution, age > 12 months.

Exclusion Criteria

age < 12 months

Addresses

Primary Sponsor

Address:
Klinik für Kinder- und Jugendmedizin Universitätsklinikum Köln
Kerpener Str. 62
50924 Köln
Germany
Telephone:
No Entry
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry
Investigator Sponsored/Initiated Trial (IST/IIT):
Yes

Contact for Scientific Queries

Address:
Universitätsklinikum Köln
Univ.-Prof. Dr. Jörg Dötsch
Kerpener Str. 62
50924 Köln
Germany
Telephone:
+49 221 478-4350
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.medizin.uni-koeln.de

Contact for Public Queries

Address:
Universitätsklinikum Köln
Kerpener Str. 62
50924 Köln
Germany
Telephone:
+49 221 478-78903
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.medizin.uni-koeln.de

Principal Investigator

Address:
Universitätsklinikum Köln
Univ.-Prof. Dr. Jörg Dötsch
Kerpener Str. 62
50924 Köln
Germany
Telephone:
+49 221 478-4350
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.medizin.uni-koeln.de

Sources of Monetary or Material Support

Public funding institutions financed by tax money/Government funding body (German Research Foundation (DFG), Federal Ministry of Education and Research (BMBF), etc.)

Address:
Bundesministerium für Bildung und Forschung Dienstsitz Berlin
Friedrichstraße 130 B
10117 Berlin
Germany
Telephone:
No Entry
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Ethics Committee

Address Ethics Committee

Address:
Ethikkommission der Medizinischen Fakultät der Universität zu Köln
Gleueler Str. 269
50935 Köln
Germany
Telephone:
+49-221-478 82900
Fax:
+40-221-478 82905
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Vote of leading Ethics Committee

Vote of leading Ethics Committee
Date of ethics committee application:
2020-09-10
Ethics committee number:
20-1463_1, 20-1463_2
Vote of the Ethics Committee:
Approved
Date of the vote:
2020-10-16

Further identification numbers

Other primary registry ID:
No Entry
EudraCT Number:
No Entry
UTN (Universal Trial Number):
No Entry
EUDAMED Number:
No Entry

IPD - Individual Participant Data

Do you plan to make participant-related data (IPD) available to other researchers in an anonymized form?:
Yes
IPD Sharing Plan:
Data will be shared with the Partners in B-FAST through a Plattform that will be used by B-FAST-Partners only

Study protocol and other study documents

Study protocols:
No Entry
Study abstract:
No Entry
Other study documents:
No Entry
Background literature:
No Entry
Related DRKS studies:
No Entry

Publication of study results

Planned publication:
No Entry
Publikationen/Studienergebnisse:
Publikation Lancet EClinicalMedicine
Date of first publication of study results:
No Entry
DRKS entry published for the first time with results:
No Entry

Basic reporting

Basic Reporting / Results tables:
No Entry
Brief summary of results:
No Entry